Mark Tannenbaum

4.1k total citations · 1 hit paper
28 papers, 1.7k citations indexed

About

Mark Tannenbaum is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Tannenbaum has authored 28 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 20 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Tannenbaum's work include Acute Myocardial Infarction Research (12 papers), Coronary Interventions and Diagnostics (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Mark Tannenbaum is often cited by papers focused on Acute Myocardial Infarction Research (12 papers), Coronary Interventions and Diagnostics (10 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Mark Tannenbaum collaborates with scholars based in United States, Canada and Australia. Mark Tannenbaum's co-authors include Valentı́n Fuster, John A. Ambrose, Susan Borrico, Dimitrios Alexopoulos, Melvin B. Weiss, Richard Gorlin, Jeffrey A. Leavy, Craig E. Hjemdahl-Monsen, Alan Niederman and Dean J. Kereiakes and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Contemporary Sociology A Journal of Reviews.

In The Last Decade

Mark Tannenbaum

27 papers receiving 1.6k citations

Hit Papers

Angiographic progression ... 1988 2026 2000 2013 1988 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Angiographic progression of coronary artery disease and the development of myocardial infarction
    1988 1.0k citations John A. Ambrose, Mark Tannenbaum et al. Journal of the American College of Cardiology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark Tannenbaum 1.1k 1.0k 825 446 190 28 1.7k
Cass A. Pinkerton 2.0k 1.8× 1.5k 1.5× 1.1k 1.3× 692 1.6× 151 0.8× 50 2.5k
Makoto Orii 839 0.8× 681 0.7× 643 0.8× 357 0.8× 48 0.3× 77 1.3k
Robert J. Chisholm 913 0.9× 1.1k 1.1× 385 0.5× 591 1.3× 224 1.2× 55 2.0k
Yoshisato Shibata 1.5k 1.4× 1.2k 1.2× 802 1.0× 499 1.1× 81 0.4× 122 2.2k
Krzysztof Milewski 1.2k 1.1× 1.2k 1.2× 506 0.6× 339 0.8× 142 0.7× 136 1.8k
Michael L. Stadius 919 0.9× 978 1.0× 710 0.9× 215 0.5× 51 0.3× 35 1.5k
Anita L. Tang 762 0.7× 749 0.7× 511 0.6× 311 0.7× 35 0.2× 8 1.4k
Rudolf Blasini 2.2k 2.0× 2.6k 2.5× 997 1.2× 355 0.8× 364 1.9× 25 3.1k
R. Uebis 853 0.8× 1.4k 1.4× 944 1.1× 281 0.6× 142 0.7× 52 1.9k
Aris Moschovitis 1.5k 1.4× 1.7k 1.7× 593 0.7× 495 1.1× 156 0.8× 66 2.3k

Countries citing papers authored by Mark Tannenbaum

Since Specialization
Citations

This map shows the geographic impact of Mark Tannenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Tannenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Tannenbaum more than expected).

Fields of papers citing papers by Mark Tannenbaum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Tannenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Tannenbaum. The network helps show where Mark Tannenbaum may publish in the future.

Co-authorship network of co-authors of Mark Tannenbaum

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Tannenbaum. A scholar is included among the top collaborators of Mark Tannenbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Tannenbaum. Mark Tannenbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aguirre, Frank V., Jenny Chambers, Scott W. Sharkey, et al.. (2022). STEMI: Considerations for Left Main Culprit Lesions. Current Cardiology Reports. 24(6). 645–651. 5 indexed citations
2.
Ahsan, Muhammad Junaid, Azka Latif, Noman Lateef, et al.. (2022). Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analysis. European Heart Journal - Quality of Care and Clinical Outcomes. 8(6). 640–650. 5 indexed citations
3.
Megaly, Michael, Mehmet Yildiz, Marshall Dworak, et al.. (2021). Incidence and Long‐Term Outcomes of Stroke in Patients Presenting With ST‐Segment Elevation–Myocardial Infarction: Insights From the Midwest STEMI Consortium. Journal of the American Heart Association. 10(23). e022489–e022489. 3 indexed citations
4.
Hamilton, Russell J., et al.. (2021). Coronary artery aneurysm presenting as acute coronary syndrome: two case reports and a review of the literature. Journal of Thrombosis and Thrombolysis. 52(2). 683–688. 4 indexed citations
5.
Megaly, Michael, Christian Schmidt, Marshall Dworak, et al.. (2021). Diabetic Patients Who Present With ST-Elevation Myocardial Infarction. Cardiovascular revascularization medicine. 38. 89–93. 8 indexed citations
6.
Karácsonyi, Judit, Christian Schmidt, Santiago García, et al.. (2021). Comparison of Outcomes of Patients with vs without Previous Coronary Artery Bypass Graft Surgery Presenting with ST-Segment Elevation Acute Myocardial Infarction. The American Journal of Cardiology. 154. 33–40. 3 indexed citations
7.
Henry, Timothy D., Santiago García, Christian Schmidt, et al.. (2020). CLINICAL OUTCOMES OF ANTERIOR STEMI PATIENTS ELIGIBLE FOR THE DOOR TO UNLOAD TRIAL. Journal of the American College of Cardiology. 75(11). 25–25. 1 indexed citations
8.
Sharkey, Scott W., Frank V. Aguirre, Mark Tannenbaum, et al.. (2020). The Midwest ST-Elevation Myocardial Infarction Consortium: Design and Rationale. Cardiovascular revascularization medicine. 23. 86–90. 12 indexed citations
9.
Duval, Sue, Mark Tannenbaum, Susan Brown, et al.. (2012). Are the Results of a Regional ST-Elevation Myocardial Infarction System Reproducible?. The American Journal of Cardiology. 109(11). 1582–1588. 8 indexed citations
10.
Suzuki, Nobuaki, Dominick J. Angiolillo, Mark Tannenbaum, et al.. (2008). Strategies for drug‐eluting stent treatment of bifurcation coronary artery disease in the United States: Insights from the e‐Cypher S.T.L.L.R.Trial. Catheterization and Cardiovascular Interventions. 73(7). 890–897. 5 indexed citations
11.
Costa, Marco A., Dominick J. Angiolillo, Mark Tannenbaum, et al.. (2008). Impact of Stent Deployment Procedural Factors on Long-Term Effectiveness and Safety of Sirolimus-Eluting Stents (Final Results of the Multicenter Prospective STLLR Trial). The American Journal of Cardiology. 101(12). 1704–1711. 167 indexed citations
12.
Teirstein, Paul S., John Kao, Matthew W. Watkins, et al.. (2005). Impact of Platelet Glycoprotein IIb/IIIa Inhibition on the Paclitaxel-Eluting Stent in Patients With Stable or Unstable Angina Pectoris or Provocable Myocardial Ischemia (A TAXUS IV Substudy). The American Journal of Cardiology. 96(4). 500–505. 9 indexed citations
13.
Lincoff, A. Michael, John A. Bittl, Neal S. Kleiman, et al.. (2004). Comparison of bivalirudin versus heparin during percutaneous coronary intervention (the Randomized Evaluation of PCI Linking Angiomax to Reduced Clinical Events [REPLACE]-1 trial). The American Journal of Cardiology. 93(9). 1092–1096. 164 indexed citations
14.
Cantor, Warren J., James E. Tcheng, James C. Blankenship, et al.. (2004). Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experience.. PubMed. 16(9). 475–81. 2 indexed citations
15.
Tannenbaum, Mark. (2003). Organizational Values and Leadership: Learn More about the Importance of Aligning Core and Operational Values in the Strategic Planning Process and the Bottom-Line Benefits of Investing in a Performance-Oriented Organizational Culture. 32(2). 19. 1 indexed citations
16.
17.
Phillips, Steven J., A Grignon, Lawrence Barker, et al.. (1992). Benefits of combined balloon pumping and percutaneous cardiopulmonary bypass. The Annals of Thoracic Surgery. 54(5). 908–910. 16 indexed citations
18.
Phillips, Steven J., et al.. (1992). Sheathless insertion of the percutaneous intraaortic balloon pump: An alternate method. The Annals of Thoracic Surgery. 53(1). 162–162. 8 indexed citations
19.
Ambrose, John A., Mark Tannenbaum, Dimitrios Alexopoulos, et al.. (1988). Angiographic progression of coronary artery disease and the development of myocardial infarction. Journal of the American College of Cardiology. 12(1). 56–62. 1021 indexed citations breakdown →
20.
Konstadt, Steven N., et al.. (1987). 45-Year-old wiman develops acute left ventricular ischemia and dysfunction after subxiphoid drainage of a pericardial tamponade. Journal of Cardiothoracic Anesthesia. 1(5). 469–478.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cass A. Pinkerton Breakdown of academic impact, for papers by Makoto Orii Breakdown of academic impact, for papers by Robert J. Chisholm Breakdown of academic impact, for papers by Yoshisato Shibata Breakdown of academic impact, for papers by Krzysztof Milewski Breakdown of academic impact, for papers by Michael L. Stadius Breakdown of academic impact, for papers by Anita L. Tang Breakdown of academic impact, for papers by Rudolf Blasini Breakdown of academic impact, for papers by R. Uebis Breakdown of academic impact, for papers by Aris Moschovitis
Rankless by CCL
2026